Atlas Venture is a private equity and venture capital firm based in Cambridge, Massachusetts, founded in 1980. The firm specializes in early-stage investments, particularly in the life sciences and technology sectors, with a strong emphasis on biotechnology and personalized medicine. Atlas Venture adopts a seed-led venture creation strategy, rigorously selecting opportunities to build scalable businesses. It typically invests between $0.25 million and $15 million per transaction, preferring to be a lead investor and to obtain board representation in its portfolio companies. The firm primarily focuses on startups in the United States and Europe, particularly in New England and the San Francisco Bay Area. Since its inception, Atlas Venture has managed over $2 billion in committed capital and has been involved in the creation and growth of numerous companies, with many achieving significant exits through acquisitions or public offerings. The firm has distinct teams dedicated to life sciences and technology investments, allowing for specialized attention in these dynamic fields.
400 Technology Square, 10th Floor Cambridge, MA 02139 USA
Laura Alessio
Director of Portfolio operations
Peter Barrett
Partner
Kevin Bitterman
Partner
Bruce Booth
Partner
Ommer Chohan
CFO
Philippe Claude
Senior Partner
Micheal Du Cros
Partner
Rajesh Devraj
Venture Partner
Maurizio Fazio Ph.D
Principal
Jean-Francois Formela
Partner
Jernej Godec
Associate
David Grayzel
Managing Director
Chelsea Place Johnson
Principal
Gerard Montanus
Senior Partner
Julia Pian
Associate
Josh Powers
Associate
Aimee Raleigh
Principal
Steven Robinette
Venture Partner
Uciane Scarlett
Associate
Jay Shiveley
Principal
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.